USPTO serial 79266494
Serial No. 79266494
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Aug 11, 2020
- Examiner
- MESSICK, TABITHA LEE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with Serial No. 79266494?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*
Plus Government fees of $425
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Yangtze River Pharmaceutical (Group) Co., Ltd.
CN
Other trademarks owned by Yangtze River Pharmaceutical (Group) Co., Ltd.
Yangtze River Pharmaceutical (Group) Co., Ltd.
CN
Other trademarks owned by Yangtze River Pharmaceutical (Group) Co., Ltd.
Yangtze River Pharmaceutical (Group) Co., Ltd.
CN
Other trademarks owned by Yangtze River Pharmaceutical (Group) Co., Ltd.
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Prakash NAMA
121 Moore St.Princeton, NJ 08540UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Medical preparations, namely, foot, hand and skin creams for diabetics; Medical preparation, namely, anti-cancer preparations; chemico-pharmaceutical preparations, namely, anti-infectives, pain relief medication, Chinese traditional medicinal herbs; radiological contrast substances for medical purposes; analgesics; drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; medicines for human purposes, namely, anti-infectives, pain relief medication, cardiovascular pharmaceuticals, digestives for pharmaceutical purposes, Chinese traditional medicinal herbs, tumor suppressing agents, X-ray contrast agents, pharmaceutical preparations acting on the central nervous system; medicinal drinks; injectable pharmaceuticals for treatment of anaphylactic reactions; medicinal ointments for treating dermatological conditions; Chinese medicine nostrum namely, medicinal herbs; pills for pharmaceutical purposes namely anti-infectives, pain relief medication, cardiovascular pharmaceuticals, digestives for pharmaceutical purposes, Chinese traditional medicinal herbs, tumor suppressing agents, X-ray contrast agents, pharmaceutical preparations acting on the central nervous system; sticking plasters for medical purposes; biochemicial drug in the nature of biological preparations for the treatment of cancer; blood for medical purposes; gelatin capsules sold empty for pharmaceuticals; alcohol for medicinal purposes; medicated eye-wash; dietetic foods adapted for medical purposes; depuratives for the body; non medicated additives for animal feed for use as nutritional supplement; vermin destroying preparations; wadding for medical purposes; preparations to facilitate teething, namely, teething gels | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Yangtze River Pharmaceutical (Group) Co., Ltd.
- Other trademarks owned by Yangtze River Pharmaceutical (Group) Co., Ltd.
- Other trademarks owned by Yangtze River Pharmaceutical (Group) Co., Ltd.
- Other trademarks in Class 005
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 20, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Aug 11, 2025 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Feb 13, 2021 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Dec 4, 2020 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Dec 3, 2020 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Nov 11, 2020 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Aug 11, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 29, 2020 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| May 26, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 26, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 13, 2020 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| May 13, 2020 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| May 6, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 18, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 17, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 16, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 16, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 20, 2019 | RFNT | REFUSAL PROCESSED BY IB | — |
| Dec 3, 2019 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Dec 2, 2019 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Nov 21, 2019 | CORR | CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED | — |
| Nov 8, 2019 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 7, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 4, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 25, 2019 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| Sep 14, 2019 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 10, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 3, 2019 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Aug 29, 2019 | SDRC | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB | — |